| Code | 33841 | ||||||||||
| MA number | 21/0173/02-S | ||||||||||
| Product Form: | tbl 30x50 mg | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Desitin Arzneimitttel GmbH, Germany | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10c informed consent application |
| MA issued: | 20.08.2002 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Plexxo 50 mg_05.2024.pdf
|
| SPC: |
SPC_Plexxo 50 mg_05.2024.pdf
|
| Safety feature | Yes |
| Data update: | 11.06.2018 |
